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j ourna l homepage: www.e lsev ie r .com/ locate / i jgoEDITORIALFIGO Cancer Report 2015The FIGO Gynecologic Oncology Committee is pleased to present the
second edition of the FIGO Cancer Report. Historically the report was
published at each FIGO World Congress as the “Annual Report,” going
as far back as 1937, and was composed of survival data from various
institutions around the world. Since 2009 the process of collating
international incidence and survival data stopped and a newCommittee
was formed. This Committee initiated the current format of the FIGO
Cancer Report and its ﬁrst edition was presented at the FIGO Congress
held in Rome, Italy, in October 2012. The Committee has since
established collaboration with the Catalan Institute of Oncology to
resurrect the data collection program. This process is now at an
advanced stage and a detailed situational analysis of institutions able
to provide care to women with gynecological cancers is being conduct-
ed aswewrite this editorial inMay 2015. Once the situational analysis is
complete the intention is to select 20 or so institutions in low- and
middle-income countries to collect incidence, stage, treatment, and
survival data. This will give us a global picture of themultiple inequities
in cancer care internationally and enable more targeted intervention by
organizations such as FIGO.
It is our intention to ensure that this, the second edition of the FIGO
Cancer Report, is disseminated aswidely as possible internationally, and
therefore the chapters are available online with Open Access. We are
also developing a mobile App of the different criteria for FIGO staging,
whichwill ensure that thosewith smart phoneswill have instant access.
The chapters contained in the report have either been updated or are
new chapters. The new chapters include trophoblastic disease, targeted
therapies for gynecological cancer, rehabilitation after treatment for
gynecological cancer, psychosexual health in gynecological cancers,
palliative care in gynecological cancer, and the future role of molecular
staging in gynecological cancer. These six new chapters are addedhttp://dx.doi.org/10.1016/j.ijgo.2015.06.024
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).to nine others that include the new staging for ovary, fallopian tube,
and peritoneum. Each chapter presents the site speciﬁc staging, the
rationale behind staging, as well as internationally accepted evidence-
based guidelines. All chapters are fully referenced and the quality of
the evidence for intervention is graded.
The current FIGO Gynecologic Oncology Committee members are:
Lynette Denny (Chair), Gynecologic Oncologist, South Africa
Michael Quinn (Co-Chair), Gynecologic Oncologist, Australia
Sergio Pecorelli (Immediate Past Chair), Gynecologic Oncologist, Italy
Adriana Bermudez, Gynecologic Oncologist, Argentina
Joanna Cain, Gynecologic Oncologist, USA
Keiichi Fujiwara, Gynecologic Oncologist, Japan
Neville Hacker, Gynecologic Oncologist, Australia
Elisabeth Åvall Lundqvist, Medical Oncologist, Sweden
Jaime Prat, Pathologist, Spain
Shyam Shrivastava, Radiation Oncologist, India
The Committee composition is likely to change during the 2015 FIGO
World Congress when the report will be released, asmembers leave the
committee after serving a six-year term. The composition of the new
Committee will be announced by the incoming President of FIGO.
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